$27.50 $0.11 per serving
Product analysis
Magnesium 500 mg pairs magnesium with vitamin B6 in a relatively focused formula. The magnesium mixture includes forms of different quality without disclosing their proportions, making its likely absorption harder to judge.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality38
The magnesium mixture combines more favorable forms with magnesium oxide, a less favorable form. Unknown proportions prevent a confident picture of the blend’s quality.
Ingredient Transparency80
Amounts and forms are disclosed clearly. The missing proportions of the magnesium forms still limit a meaningful comparison of the mixture.
Value For Money47
The magnesium mixture offers middling value in the available comparison. Vitamin B6 value remains uncertain.
Customer Satisfaction94
Customer feedback is very positive across a large review base. Satisfaction alone does not establish absorption or effectiveness.
Product Focus72
The two-ingredient formula appears well aligned with its intended uses. Its broad range of goals makes the claimed purpose less concentrated.
- Format
Capsule - Container
- 250 Capsule(s)
- Per serving
- $0.11
- Customer rating
- 4.8 · 26,261 ratings
Goals
Impact
High effect
Magnesium · 500 mg
Impact
Highest effect
Magnesium · 500 mg
Impact
High effect
Magnesium · 500 mgVitamin B6 · 5 mg
Impact
High effect
Magnesium · 500 mgVitamin B6 · 5 mg
Impact
High effect
Magnesium · 500 mgVitamin B6 · 5 mg
Impact
Moderate effect
Magnesium · 500 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin B6 (Pyridoxine Hydrochloride) | 5 mg | |
Magnesium (Magnesium Citrate, Magnesium Malate, Magnesium Oxide) | 500 mg |
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Association between Serum Magnesium and Fractures: A Systematic Review and Meta-Analysis of Observational Studies.
- Bioabsorbable Magnesium-Based Materials Potential and Safety in Bone Surgery: A Systematic Review.
- Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head.
- An update on magnesium and bone health.
- Sex-specific differences in the association of magnesium intake with femoral neck bone mineral density among older adults.
- The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial.
- Dietary B vitamin intake and risk of hip fracture: the Singapore Chinese Health Study.
- Hip fracture patients may be vitamin B6 deficient. Controlled study of serum pyridoxal-5'-phosphate.
- Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls.
- Adequate Intake and Supplementation of B Vitamins, in Particular Folic Acid, can Play a Protective Role in Bone Health.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- Association between serum pyridoxal 5'-phosphate levels and all-cause, cardiovascular mortality, and cardiovascular disease in adults: a population-based cohort study.
- Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus.
- Pyridoxine improves endothelial function in cardiac transplant recipients.
- Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
- Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.